277 results
8-K
EX-99.1
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
salaries and benefits associated with the addition of the INPEFA sales force and other increased headcount as well as increased travel and marketing
8-K
EX-99.1
5ty8qhasu4zy ybl15y
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-10.1
hvbwfdqy8
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
1u8il
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
z861edype uemoo5e
29 Dec 23
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
z2wc7wy
29 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
EX-99.1
7b48vct0ahcvjc
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
EX-99.1
b95o7lxpmw88 rub0wo
3 Aug 23
Lexicon Pharmaceuticals Reports Second Quarter 2023
4:08pm
8-K
EX-1.1
il4qnzu4tdf3t75g 35
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
s9su0i 17xd8g7xvs3xp
1 Jun 23
Prospectus supplement for primary offering
9:08pm
424B5
t871ie zclps35l6gbu
31 May 23
Prospectus supplement for primary offering
4:07pm